SCHEMBL14767674

SCHEMBL14767674

C/C(=C\CC/C(C)=C/CCc1ccoc1)CC/C=C(\C)CC/C=C(\C)CCC(C)C

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTPN2 P17706 3/20 0.56
PTPN1 P18031 3/20 0.56
DUSP3 P51452 3/20 0.56
PTPRC P08575 1/20 0.55
HIF1A Q16665 1/20 0.55
EPAS1 Q99814 1/20 0.55
TRPA1 O75762 1/20 0.42
USP7 Q93009 3/20 0.42
GSK3B P49841 3/20 0.41
ALOX15 P16050 1/20 0.41
GSK3A P49840 1/20 0.39
PPARG P37231 1/20 0.38
PPARA Q07869 1/20 0.38
KDM1A O60341 1/20 0.38
ATP1A1 P05023 1/20 0.36
ATP1B1 P05026 1/20 0.36
ATP1A3 P13637 1/20 0.36
ATP1B2 P14415 1/20 0.36
ATP1A2 P50993 1/20 0.36
ATP1B3 P54709 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14767620 1.00 PTPN2 (0.56) PTPN2PTPN1DUSP3PTPRCHIF1A
SCHEMBL14767666 0.92 PTPN1 (0.61) PTPN2PTPN1DUSP3PTPRCHIF1A
SCHEMBL14767672 0.89 PTPN2 (0.59) PTPN2PTPN1DUSP3PTPRCHIF1A
SCHEMBL13015023 0.89 PTPN1 (0.59) PTPN2PTPN1DUSP3PTPRCHIF1A
SCHEMBL14767629 0.89 PTPN2 (0.59) PTPN2PTPN1DUSP3PTPRCHIF1A
SCHEMBL14767652 0.85 HIF1A (0.59) PTPN2PTPN1DUSP3PTPRCHIF1A
SCHEMBL31508572 0.85 HIF1A (0.59) PTPN2PTPN1DUSP3PTPRCHIF1A
SCHEMBL11886113 0.85 HIF1A (0.59) PTPN2PTPN1DUSP3PTPRCHIF1A
SCHEMBL17849951 0.84 HIF1A (0.58) PTPN2PTPN1DUSP3PTPRCHIF1A
SCHEMBL14767592 0.84 HIF1A (0.58) PTPN2PTPN1DUSP3PTPRCHIF1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9371301-B2 Prenylarene compound and use thereof OSAKA UNIVERSITY (JP) 2016-06-21 US disclosed
US-9371301-B2 Prenylarene compound and use thereof OSAKA UNIVERSITY (JP) 2016-06-21 US disclosed
US-20130065937-A1 NOVEL PRENYLARENE COMPOUND AND USE THEREOF OSAKA UNIVERSITY (JP) 2013-03-14 US disclosed
US-20130065937-A1 NOVEL PRENYLARENE COMPOUND AND USE THEREOF OSAKA UNIVERSITY (JP) 2013-03-14 US disclosed
EP-2567956-A1 NOVEL PRENYLARENE COMPOUND AND USE THEREOF Osaka University (JP) 2013-03-13 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130065937-A1 NOVEL PRENYLARENE COMPOUND AND USE THEREOF H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16, NR1H3, HIF1AN PTPN2 4565/4885PTPN1 4526/4885DUSP3 4622/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.